NM_001378183.1:c.1758+17C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378183.1(PIEZO2):​c.1758+17C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0456 in 1,467,848 control chromosomes in the GnomAD database, including 1,795 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.038 ( 147 hom., cov: 32)
Exomes 𝑓: 0.046 ( 1648 hom. )

Consequence

PIEZO2
NM_001378183.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.140

Publications

1 publications found
Variant links:
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
  • Gordon syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • arthrogryposis, distal, with impaired proprioception and touch
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
  • arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • connective tissue disorder
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Marden-Walker syndrome
    Inheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 18-10794755-G-A is Benign according to our data. Variant chr18-10794755-G-A is described in ClinVar as Benign. ClinVar VariationId is 261501.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0569 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIEZO2NM_001378183.1 linkc.1758+17C>T intron_variant Intron 13 of 55 ENST00000674853.1 NP_001365112.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIEZO2ENST00000674853.1 linkc.1758+17C>T intron_variant Intron 13 of 55 NM_001378183.1 ENSP00000501957.1 A0A2H4UKA7

Frequencies

GnomAD3 genomes
AF:
0.0381
AC:
5795
AN:
152064
Hom.:
147
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00826
Gnomad AMI
AF:
0.0581
Gnomad AMR
AF:
0.0601
Gnomad ASJ
AF:
0.00721
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.0124
Gnomad FIN
AF:
0.0745
Gnomad MID
AF:
0.0159
Gnomad NFE
AF:
0.0519
Gnomad OTH
AF:
0.0316
GnomAD2 exomes
AF:
0.0366
AC:
4758
AN:
129992
AF XY:
0.0360
show subpopulations
Gnomad AFR exome
AF:
0.00761
Gnomad AMR exome
AF:
0.0522
Gnomad ASJ exome
AF:
0.00726
Gnomad EAS exome
AF:
0.00111
Gnomad FIN exome
AF:
0.0749
Gnomad NFE exome
AF:
0.0496
Gnomad OTH exome
AF:
0.0283
GnomAD4 exome
AF:
0.0465
AC:
61115
AN:
1315670
Hom.:
1648
Cov.:
25
AF XY:
0.0455
AC XY:
29626
AN XY:
650996
show subpopulations
African (AFR)
AF:
0.00776
AC:
227
AN:
29252
American (AMR)
AF:
0.0542
AC:
1759
AN:
32472
Ashkenazi Jewish (ASJ)
AF:
0.00726
AC:
175
AN:
24112
East Asian (EAS)
AF:
0.00136
AC:
48
AN:
35364
South Asian (SAS)
AF:
0.0156
AC:
1166
AN:
74854
European-Finnish (FIN)
AF:
0.0767
AC:
2642
AN:
34426
Middle Eastern (MID)
AF:
0.00696
AC:
33
AN:
4738
European-Non Finnish (NFE)
AF:
0.0515
AC:
52754
AN:
1025080
Other (OTH)
AF:
0.0417
AC:
2311
AN:
55372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
2883
5765
8648
11530
14413
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1870
3740
5610
7480
9350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0381
AC:
5792
AN:
152178
Hom.:
147
Cov.:
32
AF XY:
0.0384
AC XY:
2857
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.00821
AC:
341
AN:
41538
American (AMR)
AF:
0.0601
AC:
919
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00721
AC:
25
AN:
3468
East Asian (EAS)
AF:
0.00193
AC:
10
AN:
5178
South Asian (SAS)
AF:
0.0120
AC:
58
AN:
4818
European-Finnish (FIN)
AF:
0.0745
AC:
789
AN:
10584
Middle Eastern (MID)
AF:
0.0138
AC:
4
AN:
290
European-Non Finnish (NFE)
AF:
0.0519
AC:
3527
AN:
67994
Other (OTH)
AF:
0.0313
AC:
66
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
286
573
859
1146
1432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0442
Hom.:
265
Bravo
AF:
0.0347
Asia WGS
AF:
0.00953
AC:
33
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.25
DANN
Benign
0.43
PhyloP100
-0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55646160; hg19: chr18-10794753; API